Strides Pharma Recalls Prednisone 20 mg Due to Foreign Tablet
Strides Pharma Inc. recalls 1,032 bottles of 20 mg Prednisone tablets due to the presence of a 2.5 mg foreign tablet.
Use caution until it’s fixed
Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets
Contact the company
What happened, in plain English
Strides Pharma Inc. is recalling one specific lot of Prednisone Tablets USP, 20 mg, because a 2.5 mg tablet was found inside the bottle. This error occurred in bottles distributed nationwide across the U.S. The recall affects approximately 1,032 bottles. Read more at govinfonow.com/recall/34401-strides-pharma-recalls-prednisone-20-mg-due-to-foreign-tablet.
Source Summary by GovInfoNow · govinfonow.com/recall/34401-strides-pharma-recalls-prednisone-20-mg-due-to-foreign-tablet · Updated October 10, 2026 · FDA enforcement record: FDA #D-1330-2022
Cite this page
“Strides Pharma Recalls Prednisone 20 mg Due to Foreign Tablet.” GovInfoNow, updated October 10, 2026. https://govinfonow.com/recall/34401-strides-pharma-recalls-prednisone-20-mg-due-to-foreign-tablet. Based on FDA recall #D-1330-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1330-2022%22&limit=1).
Why it’s dangerous
The presence of a lower-dose tablet (2.5 mg) in a bottle intended for 20 mg doses can lead to incorrect medication intake. This may result in under-dosing, potentially affecting the treatment efficacy for conditions requiring precise steroid levels.
Who’s affected
Patients who have been prescribed or possess Prednisone Tablets USP, 20 mg, manufactured by Strides Pharma Science Ltd. and distributed by Strides Pharma Inc., specifically those with Lot #7248988B.
How to tell if you have this one
Check your bottle for Prednisone Tablets USP, 20 mg, in a 100-count package. Verify the NDC is 64380-785-06 and the Lot # is 7248988B with an expiration date of 9/2023.
- Brand
Strides Pharma- Category
Drug
What to do — step by step
Check Your Bottle
Verify if your Prednisone bottle matches Lot #7248988B and NDC 64380-785-06.
Contact Your Pharmacist
If you have the recalled lot, contact your pharmacy or healthcare provider for instructions on replacement or disposal.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “US Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 11 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Strides Pharma recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1330-2022 (July 19, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1330-2022 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.